Beschwerden

16 Gesundheitszustände mit evidenzbasierter Nahrungsergänzungsmittel-ForschungGesundheitsbeschwerden mit evidenzbasierter Nahrungsergänzungsmittel-Forschung

We evaluate supplements across specific hair and scalp conditions. Each condition page ranks ingredients by evidence grade, helping you find what research actually supports for your particular concern.

How We Grade Evidence

Jede Beschwerdeseite ordnet Nahrungsergänzungsmittel-Inhaltsstoffe nach der Stärke der klinischen Evidenz ein. Das bedeuten die einzelnen Bewertungsstufen:

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

Alopecia Areata

2% lifetime risk

Circular bald patches Exclamation point hairs Nail pitting

Altersbedingte Haarausdünnung

Near-universal over age 60

Gradual density reduction Finer hair texture Slower growth rate

Androgenetische Alopezie

50% of men by age 50, 25% of women by age 50

Receding hairline Crown thinning Widening part +1

Ernährungsbedingter Haarausfall

Common in restrictive diets and malabsorption conditions

Diffuse thinning Dry dull hair Slow growth +1

Haarausfall durch Eisenmangel

Affects up to 60% of premenopausal women with hair loss

Diffuse thinning Increased shedding Fatigue +1

Haarausfall durch Kopfhautpsoriasis

45-56% of psoriasis patients have scalp involvement

Thick scales Red patches Itching +1

Postpartaler Haarausfall

Affects 40-50% of women postpartum

Excessive shedding Thinning around temples Reduced hair density

Schilddrüsenbedingter Haarausfall

4-10% of general population has thyroid dysfunction

Diffuse thinning Dry brittle hair Loss of outer eyebrows

Stressbedingter Haarausfall

Increasingly common; associated with telogen effluvium

Diffuse shedding Hair thinning Slower regrowth

Telogen Effluvium

Second most common cause of hair loss

Diffuse thinning Excessive shedding Reduced ponytail volume

Traktionsalopezie

Common in certain hairstyle practices

Hairline recession Broken hairs Folliculitis

Weiblicher Haarausfall

40% of women by age 50

Widening central part Diffuse crown thinning Preserved frontal hairline

Chemotherapy-Induced Hair Loss

Affects 65-85% of chemotherapy patients depending on regimen

Rapid diffuse shedding Complete scalp hair loss Eyebrow and eyelash loss +1

Hormonal Hair Changes (PCOS & Menopause)

PCOS affects 6-12% of women; menopause-related thinning affects 40%+ of postmenopausal women

Diffuse thinning Changes in hair texture Hirsutism (PCOS) +1

Brittle Hair and Nails Syndrome

Affects approximately 20% of the general population

Dry, splitting hair Increased breakage Brittle, peeling nails +1

Scalp Inflammation (Folliculitis & Dermatitis)

Seborrheic dermatitis affects 3-5% of adults; scalp involvement very common

Scalp redness Itching and flaking Pustules around follicles +1

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.